类药物减弱了PD-L1分类到依赖于类似于ubiquitin的3修饰的小细胞外囊
Hiroshi Ageta1, Yoshihisa Shimada2, Tadahiro Nagaoka3
1Division for Therapies Against Intractable Diseases, Center for Medical Science, Fujita Health University, Toyoake, 470-1192, Aichi, Japan. hiage@fujita-hu.ac.jp.
Scientific reports
|December 15, 2025
概括
类他类药物通过抑制UBL3修饰来降低PD-L1对小细胞外囊泡 (sEVs) 的分类. 这一发现表明,他类药物可以通过降低SEV中的PD-L1水平来改善癌症免疫疗法.
科学领域:
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 小型细胞外囊泡 (sEVs) 通过RNA和蛋白质载荷促进细胞间的通信.
- 编程细胞死亡配体1 (PD-L1) 与免疫细胞上的PD-1结合,抑制了抗瘤免疫力.
- 目前免疫疗法 (例如,抗PD-L1/PD-1) 的有效性有限,需要新的策略.
研究的目的:
- 研究乌比奎丁类3 (UBL3) 在PD-L1分类到SEV中的作用.
- 为了确定他类药物是否影响UBL3介导的PD-L1分类.
- 探索UBL3,PD-L1和他类药物在癌症免疫治疗中的临床相关性.
主要方法:
- 调查了PD-L1.1.的UBL3修改.
- 评估了UBL3对PD-L1分类到SEVs的影响.
- 研究了他类药物对UBL3-PD-L1相互作用和sEV PD-L1水平的影响.
- 分析了与他类药物使用,sEV PD-L1水平和肺癌存活率相关的临床数据.
主要成果:
- 发现的UBL3修改PD-L1,调节其分类为SEV.
- 已证明,他类药物抑制了UBL3的修饰,减少了PD-L1对SEV的负载.
- 在使用他类药物的癌症患者中观察到较低的血清PD-L1sEV水平.
- 生物信息分析将UBL3和PD-L1表达与肺癌患者的存活率联系起来.
结论:
- UBL3是PD-L1对SEV进行分类的关键调节器.
- 类他类药物通过抑制UBL3修饰来降低PD-L1sEV水平.
- 将他类药物纳入癌症免疫疗法方案可能会提高治疗疗效.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:45Regulation of Nuclear Protein Sorting
3.2K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
02:04Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
01:20The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K